Zevra Therapeutics Inc (ZVRA)
4.73
-0.03
(-0.63%)
USD |
NASDAQ |
May 17, 16:00
4.73
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Revenue (TTM): 28.01M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 28.01M |
| December 31, 2023 | 27.76M |
| September 30, 2023 | 16.56M |
| June 30, 2023 | 16.54M |
| March 31, 2023 | 9.372M |
| December 31, 2022 | 10.16M |
| September 30, 2022 | 10.72M |
| June 30, 2022 | 9.812M |
| Date | Value |
|---|---|
| March 31, 2022 | 20.50M |
| December 31, 2021 | 28.65M |
| September 30, 2021 | 28.43M |
| June 30, 2021 | 28.39M |
| March 31, 2021 | 23.32M |
| December 31, 2020 | 13.29M |
| September 30, 2020 | 12.30M |
| June 30, 2020 | 21.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
9.372M
Minimum
Mar 2023
28.65M
Maximum
Dec 2021
19.10M
Average
18.53M
Median
Revenue (TTM) Benchmarks
| Perspective Therapeutics Inc | -- |
| Dare Bioscience Inc | -- |
| OptiNose Inc | 74.02M |
| Kodiak Sciences Inc | -- |
| INmune Bio Inc | 0.131M |